Sonit Handa

Former Senior Director, Global Expansion Program, Rare Disease, Horizon Therapeutics at Governing Board, The Jossleyn

Speaker

Sonit Handa, MD, MS, MBA, is a physician executive and consultant with 20+ years of experience in rare diseases, commercialization, and global product launches. He has led US and ex-US launches at Horizon Therapeutics, including UPLIZNA® and TEPEZZA®, and held senior roles at Astellas, Amgen, and Deloitte across commercial, medical affairs, and operations. As Founder of Biovance Consulting, he created the PRECISION LAUNCH™ framework to help biotech and pharma companies accelerate rare disease launches, drive operational excellence, and leverage AI-enabled insights. Sonit also serves on the Board of Directors of Josselyn, a nonprofit advancing mental health care access.